Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) Stock Price Down 6.6%

Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOMGet Free Report) traded down 6.6% during trading on Friday . The stock traded as low as C$0.29 and last traded at C$0.29. 4,800 shares changed hands during trading, an increase of 68% from the average session volume of 2,858 shares. The stock had previously closed at C$0.31.

Zomedica Pharmaceuticals Corp. (ZOM.V) Stock Performance

The company has a debt-to-equity ratio of 4.91, a quick ratio of 15.25 and a current ratio of 15.31. The stock has a market cap of C$36.73 million and a P/E ratio of -2.61. The firm’s 50 day moving average is C$0.29 and its 200 day moving average is C$0.28.

About Zomedica Pharmaceuticals Corp. (ZOM.V)

(Get Free Report)

Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.

Read More

Receive News & Ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) and related companies with MarketBeat.com's FREE daily email newsletter.